Rock Springs Capital Management as of June 30, 2022
Portfolio Holdings for Rock Springs Capital Management
Rock Springs Capital Management holds 131 positions in its portfolio as reported in the June 2022 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Humana (HUM) | 5.8 | $200M | 426k | 468.07 | |
Agilon Health (AGL) | 4.9 | $168M | 7.7M | 21.83 | |
UnitedHealth (UNH) | 4.0 | $138M | 269k | 513.63 | |
Argenx Se Sponsored Adr (ARGX) | 3.9 | $133M | 350k | 378.88 | |
Neurocrine Biosciences (NBIX) | 3.2 | $109M | 1.1M | 97.48 | |
Insulet Corporation (PODD) | 3.2 | $109M | 502k | 217.94 | |
Immunocore Hldgs Ads (IMCR) | 2.9 | $100M | 2.7M | 37.31 | |
Evolent Health Cl A (EVH) | 2.4 | $84M | 2.7M | 30.71 | |
Align Technology (ALGN) | 2.4 | $84M | 355k | 236.67 | |
IDEXX Laboratories (IDXX) | 2.3 | $79M | 224k | 350.73 | |
Ultragenyx Pharmaceutical (RARE) | 1.9 | $65M | 1.1M | 59.66 | |
Agios Pharmaceuticals (AGIO) | 1.9 | $65M | 2.9M | 22.17 | |
Sierra Oncology Com New | 1.9 | $65M | 1.2M | 54.99 | |
Intuitive Surgical Com New (ISRG) | 1.7 | $60M | 299k | 200.71 | |
Horizon Therapeutics Pub L SHS | 1.7 | $60M | 746k | 79.76 | |
Pacira Pharmaceuticals (PCRX) | 1.7 | $59M | 1.0M | 58.30 | |
Edwards Lifesciences (EW) | 1.7 | $57M | 602k | 95.09 | |
Mirati Therapeutics | 1.7 | $57M | 845k | 67.13 | |
Karuna Therapeutics Ord | 1.6 | $56M | 442k | 126.51 | |
Aclaris Therapeutics (ACRS) | 1.6 | $55M | 3.9M | 13.96 | |
Acadia Healthcare (ACHC) | 1.5 | $51M | 754k | 67.63 | |
Penumbra (PEN) | 1.5 | $50M | 402k | 124.52 | |
Blueprint Medicines (BPMC) | 1.4 | $50M | 979k | 50.51 | |
Alnylam Pharmaceuticals (ALNY) | 1.4 | $49M | 333k | 145.85 | |
Seagen | 1.4 | $48M | 272k | 176.94 | |
Cerevel Therapeutics Hldng I (CERE) | 1.4 | $47M | 1.8M | 26.44 | |
Shockwave Med | 1.3 | $46M | 241k | 191.17 | |
Baxter International (BAX) | 1.3 | $45M | 702k | 64.23 | |
Zai Lab Adr (ZLAB) | 1.2 | $42M | 1.2M | 34.68 | |
Ascendis Pharma A/s Sponsored Adr (ASND) | 1.2 | $40M | 426k | 92.96 | |
Dex (DXCM) | 1.0 | $35M | 473k | 74.53 | |
Covetrus | 1.0 | $35M | 1.7M | 20.75 | |
Xenon Pharmaceuticals (XENE) | 1.0 | $34M | 1.1M | 30.42 | |
Nevro (NVRO) | 1.0 | $34M | 773k | 43.83 | |
West Pharmaceutical Services (WST) | 1.0 | $34M | 111k | 302.37 | |
Mirum Pharmaceuticals (MIRM) | 1.0 | $33M | 1.7M | 19.46 | |
Freshpet (FRPT) | 1.0 | $33M | 638k | 51.89 | |
Phreesia (PHR) | 0.9 | $33M | 1.3M | 25.01 | |
Sarepta Therapeutics (SRPT) | 0.9 | $32M | 428k | 74.96 | |
Irhythm Technologies (IRTC) | 0.8 | $29M | 270k | 108.03 | |
Select Sector Spdr Tr Sbi Healthcare (XLV) | 0.7 | $26M | 200k | 128.24 | |
Novavax Com New (NVAX) | 0.7 | $24M | 475k | 51.43 | |
Abcam Ads | 0.7 | $23M | 1.6M | 14.46 | |
Travere Therapeutics (TVTX) | 0.7 | $23M | 952k | 24.23 | |
Madrigal Pharmaceuticals (MDGL) | 0.7 | $23M | 318k | 71.58 | |
EXACT Sciences Corporation (EXAS) | 0.7 | $23M | 573k | 39.39 | |
BioMarin Pharmaceutical (BMRN) | 0.6 | $22M | 265k | 82.87 | |
CONMED Corporation (CNMD) | 0.6 | $21M | 223k | 95.76 | |
Dynavax Technologies Corp Com New (DVAX) | 0.6 | $21M | 1.7M | 12.59 | |
Turning Point Therapeutics I | 0.6 | $21M | 272k | 75.25 | |
Legend Biotech Corp Sponsored Ads (LEGN) | 0.6 | $20M | 356k | 55.00 | |
Cincor Pharma | 0.6 | $19M | 1.0M | 18.84 | |
Mersana Therapeutics (MRSN) | 0.5 | $19M | 4.1M | 4.62 | |
Amylyx Pharmaceuticals (AMLX) | 0.5 | $19M | 974k | 19.26 | |
Olink Hldg Ab Sponsored Ads (OLK) | 0.5 | $19M | 1.2M | 15.20 | |
Prothena Corp SHS (PRTA) | 0.5 | $18M | 679k | 27.15 | |
Prometheus Biosciences | 0.5 | $18M | 645k | 28.23 | |
Accolade (ACCD) | 0.5 | $16M | 2.2M | 7.40 | |
Cytokinetics Com New (CYTK) | 0.5 | $16M | 400k | 39.29 | |
BioCryst Pharmaceuticals (BCRX) | 0.4 | $16M | 1.5M | 10.58 | |
Kymera Therapeutics (KYMR) | 0.4 | $15M | 776k | 19.69 | |
Warby Parker Cl A Com (WRBY) | 0.4 | $14M | 1.3M | 11.26 | |
Aura Biosciences (AURA) | 0.4 | $14M | 1.0M | 14.17 | |
Compass Therapeutics (CMPX) | 0.4 | $14M | 5.3M | 2.65 | |
Health Catalyst (HCAT) | 0.4 | $14M | 945k | 14.49 | |
Biomea Fusion (BMEA) | 0.4 | $13M | 1.1M | 11.98 | |
Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 0.4 | $13M | 725k | 17.72 | |
Inozyme Pharma (INZY) | 0.4 | $13M | 2.6M | 4.77 | |
Novocure Ord Shs (NVCR) | 0.4 | $12M | 175k | 69.50 | |
Arvinas Ord (ARVN) | 0.3 | $12M | 280k | 42.09 | |
Brooks Automation (AZTA) | 0.3 | $12M | 162k | 72.10 | |
Anaptysbio Inc Common (ANAB) | 0.3 | $12M | 572k | 20.30 | |
Lifestance Health Group (LFST) | 0.3 | $11M | 2.0M | 5.56 | |
Epizyme | 0.3 | $11M | 7.5M | 1.47 | |
Amicus Therapeutics (FOLD) | 0.3 | $11M | 1.0M | 10.74 | |
Relay Therapeutics (RLAY) | 0.3 | $10M | 618k | 16.75 | |
Pulmonx Corp (LUNG) | 0.3 | $10M | 702k | 14.72 | |
Immatics SHS (IMTX) | 0.3 | $9.8M | 1.1M | 8.71 | |
Orion Acquisition Corp Unit 02/19/2026 | 0.3 | $9.8M | 1.0M | 9.81 | |
Amryt Pharma Sponsored Ads | 0.3 | $9.2M | 1.3M | 6.99 | |
Celldex Therapeutics Com New (CLDX) | 0.3 | $9.0M | 336k | 26.96 | |
Chinook Therapeutics | 0.3 | $8.9M | 508k | 17.49 | |
Invitae (NVTAQ) | 0.2 | $8.5M | 3.5M | 2.44 | |
Aurinia Pharmaceuticals (AUPH) | 0.2 | $8.2M | 815k | 10.05 | |
Guardant Health (GH) | 0.2 | $8.1M | 200k | 40.34 | |
Kinnate Biopharma | 0.2 | $7.8M | 618k | 12.61 | |
Verve Therapeutics (VERV) | 0.2 | $7.7M | 504k | 15.28 | |
Nkarta (NKTX) | 0.2 | $7.6M | 616k | 12.32 | |
Gossamer Bio Note 5.000% 6/0 (Principal) | 0.2 | $7.2M | 9.6M | 0.75 | |
Mereo Biopharma Group Ads (MREO) | 0.2 | $7.0M | 6.2M | 1.12 | |
Design Therapeutics (DSGN) | 0.2 | $6.4M | 460k | 14.00 | |
Akero Therapeutics (AKRO) | 0.2 | $6.4M | 680k | 9.45 | |
Edap Tms S A Sponsored Adr (EDAP) | 0.2 | $6.2M | 910k | 6.80 | |
Rhythm Pharmaceuticals (RYTM) | 0.2 | $5.8M | 1.4M | 4.15 | |
F-star Therapeutics | 0.1 | $4.7M | 752k | 6.26 | |
Eqrx | 0.1 | $4.7M | 1.0M | 4.69 | |
Icosavax | 0.1 | $4.4M | 762k | 5.73 | |
Beam Therapeutics (BEAM) | 0.1 | $4.3M | 111k | 38.71 | |
Leap Therapeutics | 0.1 | $4.2M | 3.7M | 1.15 | |
Adaptimmune Therapeutics Sponds Adr (ADAP) | 0.1 | $4.0M | 2.4M | 1.70 | |
Xilio Therapeutics (XLO) | 0.1 | $4.0M | 1.4M | 2.92 | |
Gamida Cell SHS | 0.1 | $3.8M | 2.2M | 1.77 | |
Paratek Pharmaceuticals | 0.1 | $3.3M | 1.7M | 1.93 | |
Travere Therapeutics Note 2.500% 9/1 (Principal) | 0.1 | $3.2M | 3.3M | 0.99 | |
Bcls Acquisition Corp Com Cl A | 0.1 | $3.1M | 309k | 9.90 | |
Reneo Pharmaceuticals (RPHM) | 0.1 | $3.0M | 1.1M | 2.65 | |
Spruce Biosciences (SPRB) | 0.1 | $2.8M | 1.6M | 1.74 | |
Macrogenics (MGNX) | 0.1 | $2.8M | 955k | 2.95 | |
Fate Therapeutics (FATE) | 0.1 | $2.7M | 110k | 24.78 | |
Theseus Pharmaceuticals | 0.1 | $2.4M | 437k | 5.53 | |
Compugen Ord (CGEN) | 0.1 | $2.4M | 1.3M | 1.85 | |
Jiya Acquisition Corp Com Cl A | 0.1 | $2.0M | 206k | 9.88 | |
Fusion Pharmaceuticals | 0.1 | $2.0M | 810k | 2.49 | |
Prelude Therapeutics (PRLD) | 0.1 | $1.9M | 369k | 5.22 | |
Fulcrum Therapeutics (FULC) | 0.1 | $1.9M | 385k | 4.90 | |
Tempest Therapeutics (TPST) | 0.1 | $1.8M | 824k | 2.15 | |
Phasebio Pharmaceuticals | 0.0 | $1.7M | 2.8M | 0.60 | |
Essa Pharma Com New (EPIX) | 0.0 | $1.7M | 525k | 3.15 | |
Aeglea Biotherapeutics | 0.0 | $1.6M | 3.1M | 0.51 | |
Acelrx Pharmaceuticals | 0.0 | $1.5M | 6.3M | 0.24 | |
Radius Health Note 3.000% 9/0 (Principal) | 0.0 | $1.5M | 1.5M | 0.98 | |
Theravance Biopharma Note 3.250%11/0 (Principal) | 0.0 | $1.4M | 1.5M | 0.92 | |
Neurocrine Biosciences Note 2.250% 5/1 (Principal) | 0.0 | $1.3M | 1.0M | 1.33 | |
Vigil Neuroscience (VIGL) | 0.0 | $1.2M | 472k | 2.58 | |
Vincerx Pharma Com New (VINC) | 0.0 | $1.1M | 814k | 1.32 | |
Imara | 0.0 | $1.0M | 842k | 1.22 | |
Atreca Cl A Com (BCEL) | 0.0 | $828k | 463k | 1.79 | |
Applied Therapeutics (APLT) | 0.0 | $665k | 702k | 0.95 | |
Spero Therapeutics (SPRO) | 0.0 | $571k | 771k | 0.74 | |
Nevro Corp Note 2.750% 4/0 (Principal) | 0.0 | $466k | 500k | 0.93 | |
Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.0 | $38k | 134k | 0.28 |